Dermatitis, Eczematous Completed Phase Trials for Ciclosporin (DB00091)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01149759Evaluate Reversal of Pathological Epidermal Phenotype in Severe Atopic Dermatitis (AD) With Suppression of Immune Activation During Cyclosporine A TherapyTreatment